Literature DB >> 11443249

[N,N'-bis(salicylidene)-2,2-dimethyl-1,3-propanediaminate]nickel(II) and [N,N'-bis(salicylidene)-2,2-dimethyl-1,3-propanediaminate]copper(II).

C Arici1, F Ercan, R Kurtaran, O Atakol.   

Abstract

In the title compounds, [2,2'-[2,2-dimethyl-1,3-propanediylbis(nitrilomethylidyne)]diphenolato-kappa4N,N',O,O']nickel(II), [Ni(C19H20N2O2)], and [2,2'-[2,2-dimethyl-1,3-propanediylbis(nitrilomethylidyne)]diphenolato-kappa4N,N',O,O']copper(II), [Cu(C19H20N2O2)], the Ni(II) and Cu(II) atoms are coordinated by two iminic N and two phenolic O atoms of the N,N'-bis(salicylidene)-2,2-dimethyl-1,3-propanediaminate (SALPD2-, C17H16N2O2(2-)) ligand. The geometry of the coordination sphere is planar in the case of the Ni(II) complex and distorted towards tetrahedral for the Cu(II) complex. Both complexes have a cis configuration imposed by the chelate ligand. The dihedral angles between the N/Ni/O and N/Cu/O coordination planes are 17.20 (6) and 35.13 (7) degrees, respectively.

Entities:  

Year:  2001        PMID: 11443249     DOI: 10.1107/s0108270101008150

Source DB:  PubMed          Journal:  Acta Crystallogr C        ISSN: 0108-2701            Impact factor:   1.172


  3 in total

1.  [1,1'-Diphenyl-3,3'-(propane-1,3-diyldinitrilo)dibut-1-enolato]copper(II).

Authors:  Mehdi Salehi; Soraia Meghdadi; Mehdi Amirnasr; Kurt Mereiter
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-01-17

2.  {4,4'-Dibromo-2,2'-[2,2-dimethyl-propane-1,3-diylbis(nitrilo-methyl-idyne)]diphenolato-κO,N,N',O'}copper(II).

Authors:  Hadi Kargar; Hoong-Kun Fun; Reza Kia
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-11-13

3.  Electronic and magnetic properties of the [Ni(salophen)]: An experimental and DFT study.

Authors:  Rodrigo A Mendes; José Carlos Germino; Bruno R Fazolo; Ericson H N S Thaines; Franklin Ferraro; Anderson M Santana; Romildo J Ramos; Gabriel L C de Souza; Renato G Freitas; Pedro A M Vazquez; Cristina A Barboza
Journal:  J Adv Res       Date:  2017-10-16       Impact factor: 10.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.